A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?

Saved in:

Bibliographic Details
Published in:	Lung cancer (Amsterdam, Netherlands) Vol. 145; pp. 213 - 215
Main Authors:	Sereno, María, Gutiérrez-Gutiérrez, Gerardo, Sandoval, Carmen, Falagan, Sandra, Jimenez-Gordo, Ana María, Merino, María, López-Menchaca, Ramiro, Martínez-Martin, Patricia, Roa, Silvia, Casado, Enrique
Format:	Journal Article
Language:	English
Published:	Ireland Elsevier B.V 01-07-2020 Published by Elsevier B.V
Subjects:	Betacoronavirus - pathogenicity Coronavirus Infections - complications Coronavirus Infections - drug therapy Coronavirus Infections - pathology Coronavirus Infections - virology Correspondence COVID-19 Humans Immunosuppression - adverse effects Male Middle Aged Neoplasm Staging Neutropenia - complications Neutropenia - drug therapy Neutropenia - pathology Neutropenia - virology Neutrophils - drug effects Neutrophils - pathology Neutrophils - virology Nivolumab - therapeutic use Oxygen - therapeutic use Pandemics Pneumonia - complications Pneumonia - drug therapy Pneumonia - pathology Pneumonia - virology Pneumonia, Viral - complications Pneumonia, Viral - drug therapy Pneumonia, Viral - pathology Pneumonia, Viral - virology SARS-CoV-2 Small Cell Lung Carcinoma - complications Small Cell Lung Carcinoma - drug therapy Small Cell Lung Carcinoma - pathology Small Cell Lung Carcinoma - virology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0169-5002 1872-8332
DOI:	10.1016/j.lungcan.2020.04.029